Home/Filings/4/0001209191-09-032879
4//SEC Filing

Murcray Scott 4

Accession 0001209191-09-032879

CIK 0001040666other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 8:41 PM ET

Size

15.5 KB

Accession

0001209191-09-032879

Insider Transaction Report

Form 4
Period: 2009-06-17
Murcray Scott
Principal Accounting Officer
Transactions
  • Disposition to Issuer

    Employee Stock Options (right to buy)

    2009-06-173,1260 total
    Exercise: $13.78Exp: 2017-07-02Common Stock (3,126 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2009-06-177,0000 total
    Common Stock (7,000 underlying)
  • Disposition to Issuer

    Common Stock

    2009-06-17$29.00/sh780$22,6200 total
  • Disposition to Issuer

    Restricted Stock Units

    2009-06-172,2500 total
    Common Stock (2,250 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2009-06-172,6250 total
    Common Stock (2,625 underlying)
Footnotes (8)
  • [F1]Represents restricted stock units that vested in full and were canceled pursuant to the Agreement and Plan of Merger, dated as of May 7, 2009, by and among Covidien Group S.a.r.l., VNUS Medical Technologies, Inc. (the "Issuer") and Covidien Delaware Corp. (the "Merger"). At the effective time of the Merger, these restricted stock units vested in full and were canceled in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes).
  • [F2]Prior to the effective time of the Merger, the Reporting Person was entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
  • [F3]These restricted stock units vested in full and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes).
  • [F4]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from July 1, 2008.
  • [F5]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from November 1, 2007.
  • [F6]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from July 2, 2007.
  • [F7]These options were canceled at the effective time of the Merger in exchange for a cash payment of $47,577.72, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
  • [F8]Prior to the effective time of the Merger, the shares subject to these options were scheduled to vest over four years, with 25% of the shares vesting on July 2, 2008, and 1/36th of the shares vesting monthly thereafter.

Issuer

VNUS MEDICAL TECHNOLOGIES INC

CIK 0001040666

Entity typeother

Related Parties

1
  • filerCIK 0001424842

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:41 PM ET
Size
15.5 KB